triumph trial retatrutide A summary slide of the TRIUMPH-1 data presented today by Dr. Ania Jastreboff at #ADA2026 🚨 TRIUMPH-1: Phase 3 Obesity with Retatrutide 🚨 Retatrutide 💉, a once-weekly triple hormone receptor ADA 2026: Retatrutide Revolution

However, the recent FLOW study primarily assessed for a kidney outcome and demonstrated a reduction in the progression of CKD and MACE (Clinical trial ID NCT03819153)

This mechanism has been validated in clinical trials

Metabolic & Insulin Health Insulin resistance and metabolic inflexibility Energy utilization and fat storage patterns Hormonal & Appetite Regulation GLP-1 signaling and satiety pathways Thyroid, cortisol, and sex hormone balance Nutrition & Lifestyle Factors Nutrient adequacy and dietary patterns Behavioral and lifestyle contributors to weight resistance Begin with a comprehensive medical evaluation Your journey begins with a detailed medical evaluation to assess metabolic health, weight history, nutrition, lifestyle factors, and potential contributors to weight resistance

Researchers interested in supporting skin health during rapid weight loss may want to explore peptides for anti-aging and collagen-supporting interventions that promote elastin and collagen synthesis